NCT06311786View on ClinicalTrials.gov

A Study to Look at How a Single Oral Dose of Carbon-14-Labelled [14C] BIIB091 Moves Through and is Processed by the Body in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

May 11, 2024

Study Completion Date

May 11, 2024

Conditions
Healthy Volunteer
Interventions
DRUG

[14C]-BIIB091

Administered as specified in the treatment arm.

Trial Locations (1)

78744

PPD Clinical Research Unit, Austin

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY